Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, May 1999, p. 1098-1104, Vol. 43, No. 5
Service de Bactériologie-Virologie,
Received 29 May 1998/Returned for modification 5 October
1998/Accepted 1 March 1999
Fifty-seven Salmonella enterica serotype Typhimurium
(S. typhimurium) isolates were collected from human
patients in two French hospitals, Hôpital Antoine
Béclère (Clamart, France) and Hôpital Bicêtre
(Le Kremlin-Bicêtre, France), between 1996 and 1997. Thirty of
them (52 percent) were resistant to amino-, carbeni-, and
ureidopenicillins, had reduced susceptibility to amoxicillin-clavulanic acid, were susceptible to cephalothin, and were resistant to
sulfonamides, streptomycin, chloramphenicol, and tetracyclines. All
these strains possessed a blaPSE-1-like gene
and were of phage type DT104. Ten of them were studied in more detail,
which revealed that blaPSE-1 is located on the
variable region of a class 1 integron. This integron was found to be
chromosomally located, as was another class 1 integron containing
aadA2, a streptomycin-spectinomycin resistance gene. The
reduced susceptibility to amoxicillin-clavulanic acid (and to
ticarcillin-clavulanic acid) may result from the high level of
hydrolysis of the Many reports indicate that
Salmonella enterica serotype Typhimurium (S. typhimurium) would be either the first or the second nontyphoid
Salmonella species identified worldwide (14, 20). Many S. typhimurium isolates are resistant to multiple drugs
and are most commonly resistant to ampicillin, chloramphenicol,
streptomycin, sulfonamides, and tetracyclines (8, 20, 31, 38,
42). In two French university hospitals located in the suburbs of Paris,
many S. typhimurium strains with an amino- and
ureidopenicillin resistance pattern and reduced susceptibility to
amoxicillin-clavulanic acid were isolated. The first aim of this study
was to elucidate the molecular mechanism involved in this resistance
phenotype. Theoretically, several mechanisms may explain this reduced
susceptibility to amoxicillin-clavulanic acid, including a decrease in
permeability to Bacterial strains.
The S. typhimurium strains
were isolated in 1996 and 1997 from French patients at two university
hospitals, Hôpital Antoine Béclère (Clamart, France)
and Hôpital Bicêtre (Le Kremlin-Bicêtre, France).
Both hospitals are located in the southern suburbs of Paris. The
isolates were identified with the API 20E system (bioMérieux, Marcy-l-Etoile, France), were serotyped with a slide agglutination kit
(Sanofi-Diagnostics Pasteur, Marnes-la-Coquette, France), and were
phage typed at the French National Center for Salmonellae (Institut Pasteur, Paris, France) by using a collection of 40 S. typhimurium-specific phages (1). E. coli
DH10B, E. coli JM109 (Life Technologies, Gibco BRL, Paris,
France), E. coli DH5 Susceptibility testing.
The susceptibilities of all S. typhimurium isolates to the following antibiotics were first
determined by the disc agar diffusion method performed on
Mueller-Hinton plates (Sanofi-Diagnostics Pasteur): amikacin,
amoxicillin, amoxicillin-clavulanic acid, cephalothin, cefamandole,
cefepime, cefoxitin, cefotaxime, ceftazidime, ceftriaxone,
chloramphenicol, ciprofloxacin, gentamicin, kanamycin, imipenem,
nalidixic acid, piperacillin, piperacillin-tazobactam, spectinomycin,
streptomycin, sulfonamide, tetracycline, ticarcillin, tobramycin,
trimethoprim-sulfamethoxazole.
Plasmid content, mating-out assays, curing experiments, and
genomic DNA preparations.
The plasmid DNAs of 10 S. typhimurium isolates (strains 1 to 10) were tentatively extracted
either with the Nucleobond AX kit (Macherey-Nagel, Hoerdt, France) or
by the alkaline lysis procedure (34). The putative extracted
plasmid DNA suspensions were electroporated into E. coli
JM109, and recombinant bacteria were selected on Trypticase soy agar
(TSA) plates containing either amoxicillin (100 µg/ml) or
streptomycin (50 µg/ml).
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Integron- and Carbenicillinase-Mediated Reduced Susceptibility to
Amoxicillin-Clavulanic Acid in Isolates of Multidrug-Resistant
Salmonella enterica Serotype Typhimurium DT104 from
French Patients
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-lactam rather than to the clavulanic acid
resistance properties of PSE-1 in these clonally related S. typhimurium isolates.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-Lactam resistance has often been reported in
non-S. typhi Salmonella species, and many epidemiological
studies indicate an increasing rate of resistance to aminopenicillins
within the last 10 years (8, 17, 21, 28). The molecular
mechanism of ampicillin resistance may be related to the presence of
TEM-1 and TEM-2
-lactamases or to extended-spectrum TEM derivatives
(18, 32, 44). An additional decrease in susceptibility to
amoxicillin-clavulanic acid has recently been analyzed in three
S. typhimurium isolates from patients from Romania
(7). Espinasse et al. (7) concluded that
plasmid-mediated overproduction of a TEM-1-like
-lactamase occurs in
these strains.
-lactams, as is known for Escherichia
coli (30), or the presence of a specific
-lactamase.
Indeed, the overproduction of TEM-1 and TEM-2 or SHV-1
-lactamases
or the production of oxacillinases or IRT (inhibitor-resistant TEM
derivative)
-lactamases has been reported in E. coli
(7, 23, 35). Since our strains essentially gave positive
results for
-lactamase production in a nitrocefin test in the
laboratory, we set up a variety of experiments designed to elucidate
the
-lactamase-related mechanism which was involved. In addition, a
detailed epidemiological analysis of the 10 S. typhimurium
strains was performed. None of the frequently identified mechanisms of
amoxicillin-clavulanic resistance in members of the family
Enterobactericeae was found. Instead, an integron-associated
carbenicillinase gene was found in the clonally related S. typhimurium strains.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
, and E. coli XL1-Blue
MRF'Kan (Stratagene, Paris, France) were used as recipient strains for
electroporation, mating-out assays, and cloning experiments. E. coli DH10B harboring pBR322 (38) was cultured for TEM-1
extract preparation and MIC determinations.
-lactams were then determined by an agar
dilution technique on Mueller-Hinton agar with a Steers multiple inoculator and an inoculum of 104 CFU per spot
(22). All plates were incubated at 37°C for 18 h. The
MICs of the
-lactams were determined alone or in combination with a
fixed concentration of either 2 µg of clavulanic acid per ml or 4 µg of tazobactam per ml. The MICs of the following
-lactam antibiotics for 10 representative S. typhimurium isolates
(strains 1 to 10), E. coli DH10B harboring either pLPO-1
(see below) or pBR322 (TEM-1), and the E. coli DH10B
reference strain were determined: amoxicillin and ticarcillin
(SmithKline Beecham, Nanterre, France); aztreonam and cefepime
(Bristol-Myers Squibb, Paris La-Défense, France); ceftazidime
(Glaxo, Paris, France); cefamandole, cephalothin, and moxalactam (Eli
Lilly, Saint-Cloud, France); piperacillin and tazobactam (Lederle,
Oullins, France); cefotaxime and cefpirome (Hoechst-Roussel, Paris,
France); and cefoxitin and imipenem (Merck Sharp & Dohme-Chibret,
Paris, France).
or E. coli JM109 strains obtained in vitro
was attempted by liquid and solid mating-out assays by the filter
mating technique at 37°C. Transconjugants were selected on TSA plates
containing either rifampin (150 µg/ml; Sigma, Saint-Quentin Falavier,
France) and amoxicillin (100 µg/ml) or streptomycin (50 µg/ml).
RAPD fingerprinting. (RAPD) analysis was performed as described by Williams et al. (45), with some modifications. The PCR mixture consisted of buffer (10 mM Tris-HCl [pH 8.3], 50 mM KCl, 1.5 mM MgCl2, 0.001% gelatin), the four deoxynucleotide triphosphates (Boehringer Mannheim, Meylan, France) at a concentration of 400 µM each, 150 pmol of primer, about 1 µg of genomic DNA, and 2 U of Taq DNA polymerase (Perkin-Elmer Cetus) in a total volume of 50 µl. Primers B1 (5'-GTT TCG CTC C-3'), AP1 (5'-TCA CGA TGC A-3'), and ERIC-2 (5'-AAG TAA GTG ACT GGG GTG AGC G-3') were used. Each sample was subjected to the first cycle of amplification (4 min at 94°C, 1 min at 36°C, and 2 min at 72°C) in a DNA thermal cycler 9600 (Perkin-Elmer Cetus). Each of the 35 subsequent cycles consisted of denaturation at 94°C for 1 min, annealing at 36°C for 1 min, and extension at 72°C for 2 min (for the last cycle, extension was at 72°C for 10 min). The amplified products were separated by electrophoresis in a 1.5% agarose gel (Sigma) and were visualized by UV transillumination following ethidium bromide staining. A 1-kb DNA ladder (Pharmacia Biotech) was used as a molecular size standard. The fingerprints were compared visually, and patterns were considered different when they differed by at least one amplification band, regardless of band intensity.
PFGE. Plugs were prepared according to the instructions of Bio-Rad. Genomic DNA was digested either with XbaI or with SfiI at 37°C overnight. Electrophoresis through a 1% agarose gel in 0.5× TBE (Tris-borate-EDTA) buffer was performed with a CHEF DRIII apparatus (Bio-Rad). The following conditions for migration were chosen: 14°C, 6 V/cm, and a 120° switch angle. For XbaI a run time of 12 h followed by a run time of 12 h, with two linear switch ramps of 7 and 20 s and 5 to 24 s, respectively, was used. For SfiI a run time of 24 h with a linear switch ramp of 4 to 34 s was used. The ethidium bromide-stained gel was photographed (Polaroid) under UV illumination. A bacteriophage lambda DNA ladder (Bio-Rad) was used as a DNA molecular weight marker. The chromosomal fingerprints were compared by eye and were assigned to pulsed-field gel electrophoresis (PFGE) types and subtypes (40).
Isoelectric focusing and
-lactamase assays.
Cultures of
the 10 S. typhimurium isolates were grown overnight at
37°C in 10 ml of Trypticase soy broth (TSB) containing amoxicillin at
100 µg/ml. One milliliter of each overnight culture was then grown
for 3 h at 37°C in 10 ml of TSB without antibiotic. The
bacterial suspensions were disrupted by sonification (twice for 30 s each time at 20 Hz [phospholyser Vibra Cell 300; Bioblock, Illkirch,
France]) and were centrifuged (48,000 × g, 1 h,
4°C). The residual nucleic acids in the supernatant were precipitated with 7% 0.2 M spermin (Sigma) overnight at 4°C. This suspension was
ultracentrifuged at 100,000 × g for 1 h at 4°C.
The supernatant containing the enzyme extracts was subjected to
analytical isoelectric focusing with a mini IEF 111 apparatus (Bio-Rad)
with a polyacrylamide gel containing a gradient made up of ampholytes
with a pH range of from 3 to 10 (Bio-Rad). Migration was performed with
three consecutive voltages (100 V for 15 min, 200 V for 15 min, and 450 V for 1 h). The focused
-lactamases were detected by overlaying the gel with 1 mM nitrocefin (Oxoid, Paris, France) in a 50 mM phosphate buffer (pH 7.0). The pI values were determined and compared to those for
-lactamases whose pIs are known. From recombinant plasmid pLPO-1 (see Results section), the hydrolysis parameters for the
extracted
-lactamase were determined as described previously (27). The 50% inhibitory concentrations (IC50s)
of clavulanic acid and tazobactam, the affinity constant
(Km), and Vmax values for
amoxicillin and ticarcillin relative to the Vmax
value for benzylpenicillin for PSE-1 were compared to those obtained
for TEM-1.
-lactamases from the 10 selected
S. typhimurium isolates and E. coli DH10B
harboring either pBR322 (TEM-1) or pLPO-1 (PSE-1) were obtained as
described previously (46). One unit of enzyme activity was
defined as the activity which hydrolyzed 1 nmol of amoxicillin or
ticarcillin per min per mg of protein. The total protein content was
measured with the Bio-Rad DC Protein assay kit.
Dot blot and other hybridization experiments. DNA-DNA hybridizations were performed as described by Sambrook et al. (34). Three microliters of total heat-denaturated DNA from a culture of each S. typhimurium isolate was placed on a nylon membrane (Hybond N+; Amersham, Les Ullis, France) that was lying on a Mueller-Hinton agar plate. Then, the membrane was air dried and the DNA was UV cross-linked for 2 min (UV cross-linker; Stratagene). Dot blot hybridizations were performed with the 354-bp ScaI fragment internal to blaPSE-1 (10), the 450-bp PstI-NotI fragment from recombinant plasmid pHUC37 for blaSHV-3 (24), or the 560-bp SspI-PstI fragment internal to blaTEM-1 from recombinant plasmid pBR322 (39).
Hybridizations were also performed with a gel containing EcoRV-restricted fragments of the genomic DNAs from the 10 S. typhimurium strains by using either the 354-bp ScaI fragment internal to blaPSE-1 (10), a PCR-amplified fragment (SulF [5'-CTT CGA TGA GAG CCG GCG GCG GC-3'] and SulB [5'-GCA AGG GGG AAA CCC GCG CC-3']), giving an internal probe for a sulfonamide gene (sul1) (36), a 0.6-kb EcoRI fragment of plasmid pIZ-46 for IS200 hybridizations (37), or a PCR-amplified fragment (primer 1 [5'-GAG GGT AGC GGT GAC CAT CG-3'] and primer 2 [5'-ACT GAC TTG ATG ATC TCG CC-3']), giving a 779-bp internal probe for the aadA2 gene (3). The filters were incubated for 1 h at 42°C in a prehybridization solution containing 50 mM Tris-HCl (pH 7.5), 0.1 mg of salmon sperm DNA per ml, 5× Denhardt's solution (0.1% Ficoll, 0.1% bovine serum albumin, 0.1% polyvinylpyrrolidone), 3× SSC (20× SSC is 3 M NaCl plus 0.3 M sodium citrate [pH 7]), and 30% formamide. All probes were radiolabelled with [
32P]dATP by using
a random-primer DNA labelling kit (Boehringer Mannheim, Meylan,
France). Autoradiographies were performed by exposing the filters to
Kodak films at
80°C with intensifying screens for 18 h.
PCR for blaPSE-1 and integron detection. For each reaction, 2 µg of genomic DNA from each of the 10 S. typhimurium isolates was used. The PCR amplification for blaPSE-1 detection was performed with laboratory-designed primers (primers CARB-A [5'-GAA TGA CCA ATT TTA ACA ATC GC-3'] and CARB-B [5'-CGC TTT TAA TAC CAT CCG TGG-3']). Primers for the detection of class 1 integrons were located in the 5' conserved region (5'CS) and the 3' conserved region (3'CS) encoding the disinfectant resistance gene qacEAd1 (5'CS, 5'-GGC ATC CAA GCA GCA AG-3'; 3'CS, 5'-AAG CAG ACT TGA CCT GA-3') (16).
Cloning procedures and DNA sequencing. The PCR fragments obtained with the 5'CS and 3'CS primers and the genomic DNAs of the S. typhimurium isolates as templates were ligated into the SrfI site of pCRScript Cam SK+ (Stratagene), as recommended by the manufacturer, giving rise to either pLPO-1 or pLPO-2 (see Results section). Recombinant plasmids were transformed into electrocompetent E. coli XL1-Blue MRF'Kan and were selected on TSA plates containing chloramphenicol (30 µg/ml). The sequences of both strands of the cloned DNA fragments were determined with an Applied Biosystems sequencer (ABI 311). The nucleotide sequence and the deduced protein sequence were analyzed with software available over the Internet (22a).
| |
RESULTS |
|---|
|
|
|---|
Epidemiological data. During 1996 and 1997 a total of 57 S. typhimurium isolates were collected from hospitalized patients at the Hôpital Bicêtre and Hôpital Antoine Béclère, which are located in the suburbs of Paris. They represent 38% of all Salmonella species isolated during the period of time studied. The adult/child ratio of these strains was 11/46, and the stool specimen/other specimen ratio was 51/6.
Antibiotic susceptibility testing, dot blot hybridizations, and
phage typing.
Among the 57 strains studied, 44 were resistant to
aminopenicillins and carboxypenicillins (data not shown). In addition, 30 of these 44 isolates had reduced susceptibilities to
amoxicillin-clavulanic acid; however, they remained susceptible to
early cephalosporins such as cephalothin (data not shown). A
-lactamase extract was prepared from one of these isolates, S. typhimurium 1. The hydrolysis parameters that were determined
suggested the presence of a carbenicillinase-type enzyme (data not
shown). The dot blot hybridization results for total DNAs from the 30 S. typhimurium strains with reduced susceptibilities to
amoxicillin-clavulanic acid were negative with
blaSHV and blaTEM probes
but were positive with a blaPSE-1 probe (data
not shown). Of these 30 strains, 10 of them were further analyzed. The
MICs for the 10 strains studied were identical (Table
1). Marked resistance to amoxicillin,
ticarcillin, and piperacillin was noted, and this was reversed only
partially for amoxicillin and ticarcillin in the presence of clavulanic
acid and was reversed totally for piperacillin in the presence of
either clavulanic acid or tazobactam (Table 1). The cephalothin MICs
for the 10 S. typhimurium isolates remained low (Table 1).
These results were different from those obtained for E. coli
DH10B harboring multicopy plasmid pBR322 (TEM-1): clavulanic acid
reduced sharply the amoxicillin and ticarcillin MICs for the strain
(Table 1). Disc diffusion susceptibility assay results showed that the
30 blaPSE-1-positive S. typhimurium isolates were additionally resistant to chloramphenicol,
streptomycin-spectinomycin, the tetracyclines, and the sulfonamides.
Four of these 30 isolates were nalidixic acid resistant, including
S. typhimurium 3, which was studied in further detail, but
all isolates remained susceptible to ciprofloxacin and to all the other
aminoglycosides. Phage typing of these
blaPSE-1-positive S. typhimurium
isolates identified them to be of DT104 phage type.
|
Mating-out assays, curing experiments, and plasmid analysis. Mating-out assays and curing experiments were performed with each of the 10 S. typhimurium isolates. These assays were repeated eight times and remained unsuccessful.
Extraction of plasmids from S. typhimurium isolates followed by electroporation into E. coli and selection on streptomycin-containing plates failed to identify consistently any plasmid-containing amoxicillin- or streptomycin-resistant E. coli strains.Isoelectric focusing and
-lactamase assays.
The 10 S. typhimurium isolates produced a similar
-lactamase of pI 5.7, which corresponded to PSE-1 (10). The IC50 for this
-lactamase was similar to that for TEM-1: for PSE-1 and TEM-1,
the IC50s were 0.10 and 0.12 µM, respectively, for
clavulanic acid and 0.032 and 0.023 µM, respectively, for tazobactam.
Comparison of the kinetic parameters showed that the affinity of PSE-1
for amoxicillin and ticarcillin is lower than that of TEM-1 (Table 2). The
Vmax/Km ratio for
ticarcillin was higher for PSE-1 than for TEM-1 (Table 2). The specific
activities of the
-lactamases from the 10 S. typhimurium
isolates and E. coli harboring either pBR322 (TEM-1) or
pLPO-1 (PSE-1; see below) were 1,024 ± 130, 3,300 ± 420, and 30,100 ± 600 nmol/min/mg of protein, respectively, when
amoxicillin was used as the substrate. Similarly, the specific activities of the
-lactamases from S. typhimurium
isolates, E. coli harboring pBR322, or E. coli
harboring pLPO-1 when ticarcillin was used as substrate were 1,840 ± 20, 1,000 ± 35, and 36,700 ± 900 nmol/min/mg of protein,
respectively.
|
-Lactamase gene identification and integron analysis.
By
using blaPSE-1-specific primers, an 811-bp PCR
fragment was obtained from genomic DNA from each of the 10 S. typhimurium isolates. Direct sequencing of the PCR product from
S. typhimurium 1 revealed 100% identity with
blaPSE-1 (10). This result, together with the pI data, indicated that the 10 selected strains produced an
identical or very closely related carbenicillinase, PSE-1.
-lactam MICs for
that strain were slightly higher compared to those for the S. typhimurium strains (Table 1). A 9.5-kb EcoRV
restriction fragment of the genomic DNAs from all 30 S. typhimurium strains hybridized with a
blaPSE-1 probe and with the 1,197-bp amplicon
used as a probe (Fig. 2). A similar
1,197-bp PCR product was found in the 30 S. typhimurium
isolates possessing blaPSE-1 (data not shown).
|
|
Random PCR, PFGE, and IS200 hybridizations. Analysis of the 10 S. typhimurium strains by random PCR gave identical and indistinguishable electrophoresis patterns, whichever primer was used (data not shown). PFGE of XbaI- and SfiI-restricted S. typhimurium DNAs indicated that the 10 S. typhimurium strains were very closely related (Fig. 3 and data not shown). Hybridization of EcoRV-digested genomic DNAs from the 10 S. typhimurium isolates with an internal IS200 probe gave banding patterns which confirmed the clonal relationship of these strains (Fig. 4).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Our results indicate that among 57 S. typhimurium
isolates, 44 (77%) were resistant to amoxicillin (and
carboxypenicillins), which is an uncommonly high rate. Thirty of these
44 amoxicillin-resistant strains had reduced susceptibilities to
amoxicillin-clavulanic acid. During a 22-month study, Kambal
(13) analyzed the susceptibilities of 153 Salmonella isolates, of which 41% were of serogroup B and which mainly includes S. typhimurium species. All the
ampicillin-resistant isolates were
-lactamase producers and had
reduced susceptibilities to ampicillin-sulbactam. Similarly, 61% of
the ampicillin-resistant Salmonella isolates reported by
Ling et al. (17) showed similar reduced susceptibilities to
ampicillin-sulbactam (17). Recently, Seyfarth et al.
(38) detected ampicillin-resistant strains, and these
accounted for 12% of S. typhimurium isolates from humans. In addition, all ampicillin-resistant clones had reduced
susceptibilities to ampicillin-sulbactam. In the United Kingdom,
epidemic S. typhimurium phage type DT104 strains of both
animal and animal food origins have been reported to be resistant to
multiple antibiotics (44). In a recent study conducted in
the United States, S. typhimurium DT104 isolates resistant
to ampicillin, chloramphenicol, sulfonamide, tetracycline, and
streptomycin were found to be involved in an epidemic (8).
However, no information concerning their amoxicillin-clavulanic acid
susceptibilities was provided. These multiple-antibiotic-resistant strains represented 34% of S. typhimurium strains isolated
in the United States in 1996. Identical resistance profiles were found
among our 30 carbenicillinase-positive S. typhimurium
strains. In addition, strain typing revealed the same DT104 phage type.
None of these studies investigated the molecular mechanism that
explains the
-lactam resistance profile. Hybridization experiments, PCR amplifications, and sequencing of the PCR products revealed that
our S. typhimurium isolates possessed
blaPSE-1. PSE-1 (also named CARB-2), which was
first identified from Pseudomonas aeruginosa PU21-RPL11
(18), is a member of the carbenicillinase group 2c of the
Bush functional classification (4, 10). This
carbenicillinase has also been reported in some enterobacterial
species, especially Proteus mirabilis, Acinetobacter
calcoaceticus, and Alcaligenes xylosoxidans (6,
11, 12, 25). Medeiros et al. (19) found other
carbenicillinases in Salmonella enteritidis. Comparison of
the amino acid sequences among carbenicillinases shows that these class
A enzymes share 34 to 99% amino acid identity (11). PSE-1,
CARB-3, and PSE-4 differ by two amino acid residues, since the other
carbenicillinases (PSE-3, GN79, and CARB-4) possess only 34 to 87%
identity (11, 15).
Comparison of IC50s for TEM-1 and PSE-1 showed that these
enzymes are similarly susceptible to inhibitors (26).
However, the affinity of TEM-1 for amoxicillin (43.5 µM) is higher
than that of PSE-1 (68.4 µM). These results were not able to explain the decreased susceptibilities of the S. typhimurium strains
to amoxicillin-clavulanic that were observed. The
Vmax/Km ratio for ticarcillin only was higher with PSE-1 than with TEM-1. Additionally, when amoxicillin (best when ticarcillin) was used as the substrate, the
specific activity of the PSE-1
-lactamase obtained from S. typhimurium isolates or E. coli harboring recombinant
multicopy plasmid pLPO-1 was higher than that of TEM-1 when TEM-1 was
expressed in E. coli from the multicopy vector pBR322. As
found previously (35), the ticarcillin-clavulanic acid
resistance of PSE-1-producing strains may be due to rapid hydrolysis of
ticarcillin by PSE-1 rather than to the reduced susceptibility of the
enzyme to inhibitors (35).
Plasmid analysis and electroporation experiments failed to give reproducible results. At the early stage of our work, we were able to isolate sporadically blaPSE-1-containing plasmids that varied in size and structure as a result of experiments in which the plasmids were electroporated into E. coli. We therefore cannot rule out the possibility that the chromosomally located blaPSE-1 gene in S. typhimurium is also a part of the chromosomally integrated plasmids that are excised at a low frequency and probably under certain conditions, as is the case for some transposons which become activated at a low frequency under stress conditions.
PCR experiments followed by sequencing and subsequent cloning of the PCR products showed that blaPSE-1 was located on a 1,197-bp amplicon, which is part of the class 1 integron, and class 1 integrons are the most prevalent integrons among clinical isolates (33). In this regard, the sulfonamide gene, which is usually associated with class 1 integrons, was located in the same blaPSE-1-positive 9.5-kb EcoRV fragment from genomic DNAs from the S. typhimurium isolates.
Besides carbenicillinase genes, the
-lactamase genes reported so far
to be located in integrons encode class D (oxacillinases) or class B
(blaIMP-1) enzymes (2, 9, 29).
Interestingly, a recent study conducted with Albanian S. typhimurium isolates found integron-located and plasmid-mediated
-lactamase genes (43). However, oxacillinase genes were
identified. Therefore, integron-located
-lactamase genes of at least
Ambler class A and class D may explain the widespread amoxicillin
resistance in S. typhimurium.
While this work was in progress, a Danish group reported on eight
S. typhimurium isolates from pig herds. Those isolates
carried the same blaPSE-1 gene located on the
same PCR product of a class 1 integron. This resistance gene was
previously identified to be part of transposon Tn21
(36, 47). These animal isolates were also ampicillin
resistant, but neither a plasmid location nor a chromosomal location
for the
-lactamase gene was reported (36). Moreover, no
detailed data from an antibiotic susceptibility study were provided. A
second PCR product of another class 1 integron carrying the
aadA2 and sulfonamide genes was also identified in these
S. typhimurium isolates (3, 37, 43). These
results may indicate, when animal and human strains are closely
related, the spread of S. typhimurium strains from animals
to humans via food, as suggested before (36). Recently, the
same two integrons have also been reported among
multiple-drug-resistant S. typhimurium DT104 isolates from
animals and humans from different parts of the world but not France
(31). As opposed to our strains, these S. typhimurium strains were mostly ciprofloxacin resistant.
In our case, the sulfonamide gene was associated not only with a blaPSE-1-containing 9.5-kb EcoRV fragment but also with an aadA2-containing 3.5-kb EcoRV fragment from genomic DNAs from S. typhimurium isolates. Despite repeated attempts, no plasmid was recovered after electroporation into E. coli and selection on streptomycin-containing TSA plates, thus indicating that the aadA2 gene may not be associated with any putative chromosomally located plasmids in S. typhimurium, whereas blaPSE-1 is associated with chromosomally located plasmids in S. typhimurium.
This work identified a class 1 integron carrying blaPSE-1 as the molecular mechanism which may explain the reduced susceptibility to amoxicillin-clavulanic acid in S. typhimurium isolates of human origin. In most countries, the first-line antibiotic for the treatment of serious S. typhimurium infections is ampicillin, and the second-line agents include amoxicillin-clavulanic acid (14). The spread of this integron may lead to difficulties is the treatment of such infections when one takes into account the high incidence of resistance to other drugs such as chloramphenicol, sulfonamides, co-trimoxazole, and quinolones among S. typhimurium isolates. Finally, it would be interesting to compare our S. typhimurium DT104 strains with those recently identified in humans in the United States and in animals in Denmark to see whether they are clonally related. It would not be surprising to find that they are related since they have identical phage types and identical multiple antibiotic resistance patterns.
| |
ACKNOWLEDGMENTS |
|---|
This work was partially funded by grants from the Ministère de la Recherche et de l'Enseignement (UPRES, JE 2227) and from the Institut SmithKline Beecham (La Défense, France).
We are very grateful to Roger Labia for help with the determination of
the preliminary
-lactamase parameters and to P. A. D. Grimont for phage typing and J. Casadesus for providing plasmid pIZ46.
| |
FOOTNOTES |
|---|
* Corresponding author. Service de Bactériologie-Virologie, Hôpital de Bicêtre, 78 rue du Général Leclerc, 94275 Le Kremlin-Bicêtre Cédex, France. Phone: 33-1-45-21-36-32. Fax: 33-1-45-21-63-40. E-mail: nordmann.patrice{at}bct.ap-hop-paris.fr.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Anderson, E. S., L. R. Ward, M. J. De Saxe, and J. D. De Sa. 1977. Bacteriophage typing designations of Salmonella typhimurium. J. Hyg. (London) 78:297-300[Medline]. |
| 2. |
Arakawa, Y.,
M. Murakami,
K. Suzuki,
H. Ito,
R. Wacharotayankun,
S. Ohsuka,
N. Kato, and M. Ohta.
1995.
A novel integron-like element carrying the metallo- -lactamase gene blaIMP.
Antimicrob. Agents Chemother.
39:1612-1615[Abstract].
|
| 3. |
Bito, A., and M. Susani.
1994.
Revised analysis of aadA2 gene of plasmid pSa.
Antimicrob. Agents Chemother.
38:1172-1175 |
| 4. |
Bush, K.,
G. A. Jacoby, and A. A. Medeiros.
1995.
A functional classification scheme for -lactamases and its correlation with molecular structure.
Antimicrob. Agents Chemother.
39:1211-1233[Medline].
|
| 5. | Datta, S., A. Pal, S. Basu, and P. C. Banerjee. 1997. Involvement of a 70-kb plasmid of the epidemic Shigella dysenteriae type (Dt66) strains in drug-resistance, lipopolysaccharide synthesis and virulence. Microb. Drug. Resist. 3:351-357. [Medline] |
| 6. |
Decré, D.,
G. Arlet,
E. Bergogne-Bérézin, and A. Philippon.
1995.
Identification of a carbenicillin-hydrolyzing -lactamase in Alcaligenes denitrificans subsp. xylosoxydans.
Antimicrob. Agents Chemother.
39:771-774[Abstract].
|
| 7. |
Espinasse, F.,
R. Gheorghiu,
A. Poiata,
R. Labia, and M. H. Nicolas-Chanoine.
1997.
Reduced susceptibility to co-amoxiclav in Escherichia coli, Salmonella typhimurium and Klebsiella pneumoniae isolated in Romania between 1985 and 1993.
J. Antimicrob. Chemother.
39:103-106 |
| 8. |
Glynn, M. K.,
C. Bopp,
W. Dewitt,
P. Dabney,
M. Mokhtar, and F. Angulo.
1998.
Emergence of multidrug-resistant Salmonella enterica serotype typhimurium DT104 infections in the United States.
N. Engl. J. Med.
338:1333-1338 |
| 9. | Hall, R. M. 1997. Mobile gene cassettes and integrons moving antibiotic resistance genes in gram-negative bacteria. Ciba Found. Symp. 207:192-205[Medline]. |
| 10. |
Huovinen, P., and G. A. Jacoby.
1991.
Sequence of PSE-1 -lactamase.
Antimicrob. Agents Chemother.
35:2428-2430 |
| 11. | Ito, Y., and T. Hirano. 1997. Carbenicillin-hydrolysing penicillinase mediated by a plasmid of Proteus mirabilis and its relationship to the PSE-type enzymes of Pseudomonas aeruginosa. J. Appl. Microbiol. 83:175-180[Medline]. |
| 12. |
Joly-Guillou, M. L.,
E. Vallée,
E. Bergogne-Bérézin, and A. Philippon.
1988.
Distribution of -lactamases and phenotype analysis in clinical strains of Acinetobacter calcoaceticus.
J. Antimicrob. Chemother.
22:597-604 |
| 13. | Kambal, A. M. 1996. Antimicrobial susceptibility and serogroups of Salmonella isolates from Riyadh, Saudi Arabia. Int. J. Antimicrob. Chemother. 7:265-269. |
| 14. |
Kariuki, S.,
C. Gilks,
J. Corkill,
J. Kimari,
A. Benea,
P. Waiyaki, and C. A. Hart.
1996.
Multi-drug resistant non-typhi salmonellae in Kenya.
J. Antimicrob. Chemother.
38:425-434 |
| 15. |
Lenfant, F.,
A. Petit,
R. Labia,
L. Maveyraud,
J. P. Samama, and J. M. Masson.
1993.
Site-directed mutagenesis of -lactamase TEM-1. Investigating the potential role of specific residues on the activity of Pseudomonas-specific enzymes.
Eur. J. Biochem.
217:939-946[Medline].
|
| 16. | Lévesque, C., L. Piché, C. Larose, and P. H. Roy. 1995. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob. Agents Chemother. 39:185-191[Abstract]. |
| 17. |
Ling, J. M.,
G. M. Zhou,
T. H. Woo, and G. L. French.
1991.
Antimicrobial susceptibilities and -lactamase production of Hong Kong isolates of gastro-enteric salmonellae and Salmonella typhi.
J. Antimicrob. Chemother.
28:877-885 |
| 18. |
Matthew, M.
1979.
Plasmid-mediated -lactamases of gram-negative bacteria: properties and distribution.
J. Antimicrob. Chemother.
5:349-358 |
| 19. |
Medeiros, A. A.,
R. Hedges, and G. A. Jacoby.
1982.
Spread of a "Pseudomonas-specific" -lactamase to plasmids of enterobacteria.
J. Bacteriol.
149:700-707 |
| 20. |
Munoz, P.,
M. D. Diaz,
M. Rodriguez-Creixems,
E. Cercenado,
T. Pelaez, and E. Bouza.
1993.
Antimicrobial resistance of Salmonella isolates in a Spanish hospital.
Antimicrob. Agents Chemother.
37:1200-1202 |
| 21. | Murray, B. E. 1986. Resistance of Shigella, Salmonella and other selected enteric pathogens to antimicrobial agents. Rev. Infect. Dis. 8:S172-S181. |
| 22. | National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Wayne, Pa. |
| 22a. | National Institutes of Health. 1998. [Online.] http://www.ncbi.nlm.:nih.gov. [2 March 1999, date last accessed.] |
| 23. |
Nicolas, M. H.
1997.
Inhibitor-resistant -lactamases.
J. Antimicrob. Chemother.
40:1-3 |
| 24. |
Nicolas, M. H.,
V. Jarlier,
N. Honoré,
A. Philippon, and S. T. Cole.
1989.
Molecular characterization of the gene encoding SHV-3 -lactamase responsible for transferable cefotaxime resistance in clinical isolates of Klebsiella pneumoniae.
Antimicrob. Agents Chemother.
33:2096-2100 |
| 25. |
Paul, G.,
M. L. Joly-Guillou,
E. Bergogne-Berezin,
P. Névot, and A. Philippon.
1989.
Novel carbenicillin-hydrolyzing -lactamase (CARB-5) from Acinetobacter calcoaticus var. anitratus.
FEMS Microbiol. Lett.
59:45-50.
|
| 26. |
Payne, D. J.,
R. Cramp,
D. J. Winstanley, and D. J. Knowles.
1994.
Comparative activity of clavulanic acid, sulbactam and tazobactam against clinically important -lactamases.
Antimicrob. Agents Chemother.
38:767-772 |
| 27. |
Philippon, L. N.,
T. Naas,
A. T. Bouthors,
V. Barakett, and P. Nordmann.
1997.
OXA-18, a class D clavulanic-acid inhibited extended-spectrum -lactamase from Pseudomonas aeruginosa.
Antimicrob. Agents Chemother.
41:2188-2195[Abstract].
|
| 28. | Ramos, J. M., J. M. Ales, M. Cuenca-Estrella, R. Fernandez-Roblas, and F. Soriano. 1996. Changes in susceptibility of Salmonella enteriditidis, Salmonella typhimurium, and Salmonella virchow to six antimicrobial agents in a Spanish hospital, 1980-1994. Eur. J. Clin. Microbiol. Infect. Dis. 15:85-88[Medline]. |
| 29. | Recchia, G. D., and R. M. Hall. 1995. Gene casettes: a new class of mobile elements. Microbiology 141:3015-3027[Medline]. |
| 30. |
Reguera, J. A.,
F. Baquero,
J. C. Perez-Diaz, and J. L. Martinez.
1991.
Factors determining resistance to -lactam combined with -lactamase inhibitors in Escherichia coli.
J. Antimicrob. Chemother.
27:569-573 |
| 31. | Ridley, A., and E. J. Threlfall. 1998. Molecular epidemiology of antibiotic resistance genes in multiresistant epidemic Salmonella typhimurium DT104. Microb. Drug Resist. 4:113-118. [Medline] |
| 32. |
Rossi, A.,
H. Lopardo,
M. Woloj,
A. M. Picandet,
M. Marino,
M. Galds,
M. Radice, and G. Gutkind.
1995.
Non-typhoid Salmonella spp. resistant to cefotaxime.
J. Antimicrob. Chemother.
36:697-702 |
| 33. | Sallen, B., A. Rajoharison, S. Desvarenne, and C. Mabilat. 1995. Molecular epidemiology of integron-associated antibiotic resistance genes in clinical isolates of Enterobacteriaceae. Microb. Drug Resist. 1:195-202. [Medline] |
| 34. | Sambrook, J. E., F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 35. |
Sanders, C. C.,
J. P. Iaconis,
G. P. Bodey, and G. Samonis.
1988.
Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 -lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests.
Antimicrob. Agents Chemother.
32:1365-1369 |
| 36. | Sandvang, D., F. M. Aarestrup, and L. B. Jensen. 1997. Characterisation of integrons and antibiotic resistance genes in Danish multiresistant Salmonella enterica typhimurium DT104. FEMS Microbiol. Lett. 157:177-181[Medline]. |
| 37. | Schiaffino, A., C. R. Beuzon, S. Uzzau, G. Leori, P. Cappuccinelli, J. Casadesus, and S. Rubino. 1996. Strain typing with IS200 fingerprints in Salmonella aborturovis. Appl. Environ. Microbiol. 62:2375-2380[Abstract]. |
| 38. |
Seyfarth, A. M.,
H. C. Wegener, and N. Frimodt-Moller.
1997.
Antimicrobial resistance in Salmonella enterica subsp. enterica serovar typhimurium from humans and production animals.
J. Antimicrob. Chemother.
40:67-75 |
| 39. |
Sutcliffe, J. G.
1978.
Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322.
Proc. Natl. Acad. Sci. USA
75:3737-3741 |
| 40. | Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulse-field gel electrophoresis criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239[Medline]. |
| 41. | Tolmasky, M. E., and J. H. Crosa. 1993. Genetic organization of antibiotic resistance genes (aac(6')-Ib, aadA, and oxa-9) in the multiresistance transposon Tn1331. Plasmid 29:31-40[Medline]. |
| 42. |
Tosini, F.,
P. Visca,
I. Luzzi,
A. M. Dionisi,
C. Pezzella,
A. Petrucca, and A. Carattoli.
1998.
Class 1 integron-borne multiple-antibiotic resistance carried by IncFI and IncL/M plasmids in Salmonella enterica serotype Typhimurium.
Antimicrob. Agents Chemother.
42:3053-3058 |
| 43. |
Vatopoulos, A. C.,
E. Mainas,
E. Balis,
E. J. Threlfall,
M. Kanelopoulou,
V. Kalapothaki,
H. Malamou-Lada, and N. J. Legakis.
1994.
Molecular epidemiology of ampicillin-resistant clinical isolates of Salmonella enteritidis.
J. Clin. Microbiol.
32:1322-1325 |
| 44. | Wall, P. G., D. Morgan, K. Lamden, M. Ryan, M. Griffin, E. J. Threlfall, L. R. Ward, and B. Rowe. 1994. A case control study of infection with an epidemic strain of multiresistant Salmonella typhimurium DT104 in England and Wales. Commun. Dis. Rep. CDR Rev. 4:R130-R135[Medline]. |
| 45. |
Williams, J. G.,
A. R. Kubelik,
K. J. Livak,
J. A. Rafalski, and S. V. Tingey.
1990.
DNA polymorphisms amplified by arbitrary primers are useful as genetic markers.
Nucleic Acids Res.
18:6531-6535 |
| 46. |
Yang, Y., and D. M. Livermore.
1988.
Chromosomal -lactamase expression and resistance of -lactams antibiotics in Proteus vulgaris and Morganella morganii.
Antimicrob. Agents Chemother.
32:1385-1391 |
| 47. |
Zühlsdorf, M. T., and B. Wiedemann.
1992.
Tn21-specific structures in gram-negative bacteria from clinical isolates.
Antimicrob. Agents Chemother.
36:1915-1921 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |